Total Payments
$8,444
2024 Payments
$1,917
Companies
36
Transactions
372
Medicare Patients
6,962
Medicare Billing
$538,899
Payment Breakdown by Category
Food & Beverage$8,042 (95.2%)
Education$401.52 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,042 | 366 | 95.2% |
| Education | $401.52 | 6 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,618 | 79 | $0 (2024) |
| Amgen Inc. | $884.08 | 40 | $0 (2024) |
| Lilly USA, LLC | $709.01 | 29 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $651.49 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $598.96 | 24 | $0 (2024) |
| Incyte Corporation | $530.11 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $422.08 | 11 | $0 (2024) |
| UCB, Inc. | $388.20 | 16 | $0 (2024) |
| LEO Pharma Inc. | $346.02 | 19 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $334.26 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,917 | 81 | ABBVIE INC. ($599.08) |
| 2023 | $1,412 | 58 | Lilly USA, LLC ($242.06) |
| 2022 | $1,380 | 56 | Incyte Corporation ($256.94) |
| 2021 | $635.48 | 33 | AbbVie Inc. ($175.64) |
| 2020 | $782.34 | 37 | Amgen Inc. ($233.66) |
| 2019 | $737.82 | 35 | AbbVie, Inc. ($150.41) |
| 2018 | $991.86 | 39 | Janssen Biotech, Inc. ($174.10) |
| 2017 | $587.20 | 33 | Janssen Biotech, Inc. ($140.48) |
All Payment Transactions
372 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.68 | General |
| Category: Immunology | ||||||
| 12/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.11 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $77.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.59 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $12.89 | General |
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.10 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: DERMATOLOGY | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Immunology | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Immunology | ||||||
| 08/07/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,008 | 3,647 | $491,698 | $145,855 |
| 2022 | 16 | 1,887 | 3,234 | $492,692 | $154,205 |
| 2021 | 16 | 1,651 | 2,802 | $423,507 | $136,456 |
| 2020 | 17 | 1,416 | 2,415 | $327,240 | $102,383 |
Total Patients
6,962
Total Services
12,098
Medicare Billing
$538,899
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 664 | 968 | $181,829 | $54,036 | 29.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 386 | 526 | $83,708 | $19,330 | 23.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 174 | 220 | $47,146 | $14,751 | 31.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 151 | 175 | $41,227 | $13,347 | 32.4% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 22 | 27 | $18,739 | $8,268 | 44.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 273 | 1,366 | $20,244 | $6,526 | 32.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 29 | 29 | $18,670 | $6,381 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 50 | $13,325 | $4,591 | 34.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 88 | 95 | $10,946 | $3,698 | 33.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 38 | 38 | $10,225 | $3,374 | 33.0% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 22 | 26 | $15,612 | $3,195 | 20.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 18 | $6,668 | $2,184 | 32.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 22 | $11,583 | $2,173 | 18.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 40 | 46 | $5,156 | $1,827 | 35.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,013 | $1,147 | 38.1% |
| 69100 | Biopsy of ear | Office | 2023 | 15 | 16 | $3,424 | $960.37 | 28.0% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2023 | 12 | 12 | $183.60 | $68.52 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 646 | 906 | $170,183 | $52,099 | 30.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 53 | 68 | $47,195 | $21,141 | 44.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 337 | 452 | $71,931 | $18,148 | 25.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 163 | 197 | $42,217 | $12,922 | 30.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 131 | 153 | $36,044 | $12,065 | 33.5% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2022 | 50 | 55 | $33,025 | $9,224 | 27.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 228 | 1,088 | $16,124 | $5,600 | 34.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 22 | 24 | $15,451 | $5,338 | 34.5% |
About Dr. Gretchen Korver, M.D
Dr. Gretchen Korver, M.D is a Dermatology healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164456414.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gretchen Korver, M.D has received a total of $8,444 in payments from pharmaceutical and medical device companies, with $1,917 received in 2024. These payments were reported across 372 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($8,042).
As a Medicare-enrolled provider, Korver has provided services to 6,962 Medicare beneficiaries, totaling 12,098 services with total Medicare billing of $538,899. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Reno, NV
- Active Since 07/11/2006
- Last Updated 03/30/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1164456414
Products in Payments
- Enbrel (Biological) $647.04
- SKYRIZI (Biological) $643.16
- TALTZ (Drug) $590.14
- OPZELURA (Drug) $530.11
- DUPIXENT (Biological) $458.72
- RINVOQ (Biological) $443.98
- Tremfya (Drug) $312.76
- Otezla (Drug) $293.46
- ILUMYA (Biological) $291.02
- TREMFYA (Drug) $269.96
- Bimzelx (Biological) $225.49
- EUCRISA (Drug) $181.14
- STELARA (Biological) $181.13
- Humira (Biological) $179.32
- ADBRY (Biological) $175.82
- BOTOX (Biological) $175.29
- ENSTILAR (Drug) $170.20
- COSENTYX (Biological) $168.45
- Cimzia (Drug) $162.71
- HUMIRA (Biological) $148.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Reno
Laura Ostezan, M.d, M.D
Dermatology — Payments: $27,692
Dermatology $27,692
Laura Biehle, Pa-C, PA-C
Dermatology — Payments: $25,736
Dermatology $25,736
Dr. William Mortensen, M.d, M.D
Dermatology — Payments: $12,827
Dermatology $12,827
Mrs. Diane Smith, Aprn, APRN
Dermatology — Payments: $11,999
Dermatology $11,999
Mrs. Cindy Lamerson, Md, MD
Dermatology — Payments: $8,873
Dermatology $8,873
Dr. Billie Casse, D.o, D.O
Dermatology — Payments: $8,184
Dermatology $8,184